Letrozole-associated controlled ovarian hyperstimulation in breast cancer patients versus conventional controlled ovarian hyperstimulation in infertile patients: assessment of oocyte quality related biomarkers
Authors:
- Oranite GoldratOGOranite Goldrat
- Geraldine Van Den SteenGSGeraldine Van Den Steen
- Eric Gonzalez-MerinoEGEric Gonzalez-Merino
- Julie DechèneJDJulie Dechène
- Christine GervyCGChristine Gervy
- Anne DelbaereADAnne Delbaere
- Fabienne DevrekerFDFabienne Devreker
- Viviane De MaertelaerVMViviane De Maertelaer
- Isabelle DemeestereIDIsabelle Demeestere
Open Access
- 3 January 2019
- journal article
- research article
- Published by Springer Nature in Reproductive Biology and Endocrinology
- Vol. 17 (1) , 1-9
Abstract
Fertility preservation (FP) protocols in case of breast cancer (BC) include mature oocyte cryopreservation following letrozole associated controlled ovarian hyperstimulation (Let-COH). To date, the impact of Let-COH on the follicular microenvironment has been poorly investigated, although a high androgen/estrogen ratio was previously associated with low oocyte quality. In this prospective study, follicular fluid (FF) steroid levels (estradiol, testosterone, progesterone) and cumulus cell (CC) gene expression related to oocyte quality (HAS2, PTGS2, GREM1) were compared between 23 BC patients undergoing Let-COH for FP and 24 infertile patients undergoing conventional COH without letrozole. All patients underwent an antagonist COH cycle, and ovulation was triggered with hCG or GnRHa in both groups. FF estradiol levels were significantly lower while testosterone levels were significantly higher in the study group compared to controls irrespective of the trigger method. However, estradiol levels increased significantly with GnRHa triggering compared to hCG in the study group (median = 194.5 (95.4–438) vs 64.4 (43.8–152.4) ng/ml, respectively, p < 0.001), but not in the control group (median = 335.5 (177.5–466.7) vs 354 (179–511) ng/ml, respectively). After hCG trigger, Cumulus cell (CC) gene expression was lower in the study group compared to the control group, and difference was significant for PTGS2. Conversely, CC gene expression of PTGS2 and GREM1 was significantly higher in the study group compared to controls when ovulation was triggered with GnRHa. Let-COH triggered with hCG may negatively impact oocyte quality. However, ovulation triggering with GnRHa may improve the oocyte microenvironment and cumulus cell genes expression in Let-COH, suggesting a positive impact on oocyte quality in breast cancer patients. Clinicaltrials.gov - NCT02661932 , registered 25 January 2016, retrospectively registered.Keywords
Funding Information
- Fonds De La Recherche Scientifique - FNRS (7.4612.13)
- Fonds De La Recherche Scientifique - FNRS (7.4528.15)
This publication has 40 references indexed in Scilit:
- Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trialThe Lancet, 2013
- Comparative Gene Expression Profiling in Human Cumulus Cells according to Ovarian Gonadotropin TreatmentsBioMed Research International, 2013
- Random-start controlled ovarian hyperstimulation for emergency fertility preservation in letrozole cyclesFertility and Sterility, 2011
- Human cumulus cells as biomarkers for embryo and pregnancy outcomesMolecular Human Reproduction, 2010
- Follicular fluid content and oocyte quality: from single biochemical markers to metabolomicsReproductive Biology and Endocrinology, 2009
- Increased intrafollicular androgen levels affect human granulosa cell secretion of anti-müllerian hormone and inhibin-BFertility and Sterility, 2008
- Fertility Preservation in Breast Cancer Patients: A Prospective Controlled Comparison of Ovarian Stimulation With Tamoxifen and Letrozole for Embryo CryopreservationJournal of Clinical Oncology, 2005
- Comprehensive Pharmacology and Clinical Efficacy of Aromatase InhibitorsDrugs, 1999
- Differential regulation of aromatase and androgen receptor in granulosa cellsThe Journal of Steroid Biochemistry and Molecular Biology, 1997
- Highly selective inhibition of estrogen biosynthesis by CGS 20267, a new non-steroidal aromatase inhibitorThe Journal of Steroid Biochemistry and Molecular Biology, 1990